• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卫生技术的经济评估与合理推广及应用

Economic evaluation and the rational diffusion and use of health technology.

作者信息

Drummond M F

出版信息

Health Policy. 1987 Jun;7(3):309-24. doi: 10.1016/0168-8510(87)90072-8.

DOI:10.1016/0168-8510(87)90072-8
PMID:10312123
Abstract

In principle, economic evaluation provides a suitable framework for the assessment of the costs and benefits of health technologies. However, despite a rapid growth in the publication of cost-effectiveness and cost-benefit analysis in health care, there is little evidence that economic evaluation has yet become part of an integrated approach to technology assessment. This paper, based on the findings of a European Community project on economic appraisal of health technology, discusses how the design and conduct of economic evaluations can be improved so as to increase their relevance to health care decision making, and how policies on the diffusion and use of health technology can be devised so as to make fuller use of the economic evaluations that are carried out.

摘要

原则上,经济评估为评估卫生技术的成本和效益提供了一个合适的框架。然而,尽管卫生保健领域成本效益分析和成本效益分析的出版物迅速增加,但几乎没有证据表明经济评估已成为技术评估综合方法的一部分。本文基于欧洲共同体一项关于卫生技术经济评估项目的研究结果,讨论了如何改进经济评估的设计和实施,以提高其与卫生保健决策的相关性,以及如何制定卫生技术推广和使用政策,以便更充分地利用所进行的经济评估。

相似文献

1
Economic evaluation and the rational diffusion and use of health technology.卫生技术的经济评估与合理推广及应用
Health Policy. 1987 Jun;7(3):309-24. doi: 10.1016/0168-8510(87)90072-8.
2
Evaluation of health technology: economic issues for health policy and policy issues for economic appraisal.卫生技术评估:卫生政策中的经济问题与经济评估中的政策问题。
Soc Sci Med. 1994 Jun;38(12):1593-600. doi: 10.1016/0277-9536(94)90059-0.
3
Current status of economic appraisal of health technology in the European Community: report of the network. The EC Network on the Methodology of Economic Appraisal of Health Technology.欧洲共同体卫生技术经济评估的现状:网络报告。欧洲共同体卫生技术经济评估方法网络
Soc Sci Med. 1994 Jun;38(12):1601-7. doi: 10.1016/0277-9536(94)90060-4.
4
The U.K. NHS economic evaluation database. Economic issues in evaluations of health technology.
Int J Technol Assess Health Care. 2000 Summer;16(3):731-42. doi: 10.1017/s0266462300102016.
5
Economic evaluation and health care decision-making.经济评估与医疗保健决策
Health Policy. 1996 Jun;36(3):215-29. doi: 10.1016/0168-8510(96)00814-7.
6
Standardizing economic appraisal of health technology in the European Community.
Soc Sci Med. 1994 Jun;38(12):1675-8. doi: 10.1016/0277-9536(94)90069-8.
7
Economic appraisal in the British National Health Service: implications of recent developments.英国国民医疗服务体系中的经济评估:近期发展的影响
Soc Sci Med. 1994 Jun;38(12):1615-23. doi: 10.1016/0277-9536(94)90062-0.
8
Allocating resources.分配资源。
Int J Technol Assess Health Care. 1990;6(1):77-92. doi: 10.1017/s0266462300008941.
9
Strategies for successful evaluation and policy-making toward health care technology on the move: the case of medical lasers.移动医疗技术成功评估与决策的策略:以医用激光为例。
Soc Sci Med. 1994 Jun;38(12):1663-74. doi: 10.1016/0277-9536(94)90068-x.
10
Researcher-driven versus policy-driven economic appraisal of health technologies: the case of France.研究者驱动与政策驱动的卫生技术经济评估:以法国为例。
Soc Sci Med. 1994 Jun;38(12):1625-33. doi: 10.1016/0277-9536(94)90063-9.

引用本文的文献

1
Health Technology Assessment Development in Vietnam: A Qualitative Study of Current Progress, Barriers, Facilitators, and Future Strategies.越南卫生技术评估发展:当前进展、障碍、促进因素和未来战略的定性研究。
Int J Environ Res Public Health. 2021 Aug 22;18(16):8846. doi: 10.3390/ijerph18168846.
2
Epistemic communities and experts in health policy-making.知识共同体与卫生政策制定专家。
Eur J Public Health. 2018 Nov 1;28(suppl_3):7-10. doi: 10.1093/eurpub/cky156.
3
Economic evaluations of health technologies in Dutch healthcare decision-making: a qualitative study of the current and potential use, barriers, and facilitators.
荷兰医疗保健决策中卫生技术的经济评估:对当前和潜在用途、障碍及促进因素的定性研究
BMC Health Serv Res. 2017 Jan 26;17(1):89. doi: 10.1186/s12913-017-1986-9.
4
Bridging the gap between the economic evaluation literature and daily practice in occupational health: a qualitative study among decision-makers in the healthcare sector.弥合经济评估文献与职业健康实践之间的差距:医疗保健领域决策者的定性研究。
Implement Sci. 2013 Jun 3;8:57. doi: 10.1186/1748-5908-8-57.
5
The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life.生活质量评估(AQoL)工具:一种与健康相关生活质量的心理测量方法。
Qual Life Res. 1999 May;8(3):209-24. doi: 10.1023/a:1008815005736.
6
The Australian Guidelines for subsidisation of pharmaceuticals: the road to cost-effective drug prescribing?澳大利亚药品补贴指南:实现具有成本效益的药物处方之路?
Pharmacoeconomics. 1992 Nov;2(5):355-62. doi: 10.2165/00019053-199202050-00003.
7
Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals.作为补贴决策辅助手段的经济分析:澳大利亚药品指南的制定
Pharmacoeconomics. 1992 Jan;1(1):54-67. doi: 10.2165/00019053-199201010-00010.
8
Australian guidelines for cost-effectiveness studies of pharmaceuticals: the thin end of the boomerang?澳大利亚药品成本效益研究指南:回旋镖的薄刃一端?
Pharmacoeconomics. 1992;1(Suppl 1):61-9. doi: 10.2165/00019053-199200011-00014.
9
Cost-effectiveness of alpha-1 antitrypsin replacement therapy in treatment of congenital chronic obstructive pulmonary disease.α-1抗胰蛋白酶替代疗法治疗先天性慢性阻塞性肺疾病的成本效益
Am J Public Health. 1991 Apr;81(4):427-33. doi: 10.2105/ajph.81.4.427.
10
The cost-effectiveness of orphan drugs.孤儿药的成本效益。
Am J Public Health. 1991 Apr;81(4):414-5. doi: 10.2105/ajph.81.4.414.